Alpha 2.0
Login Register
» Articles » PMID: 18701610

Contrast-induced Acute Kidney Injury: is There a Risk After Intravenous Contrast?

Overview
Journal Clin J Am Soc Nephrol
Specialty Nephrology
Date 2008 Aug 15
PMID 18701610
Citations 27
Authors
Richard Solomon
Affiliations
Soon will be listed here.
Citing Articles

Baseline eGFR cutoff for increased risk of post-contrast acute kidney injury in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction in the emergency department.

You J, Cho J, Shin H, Beom J PLoS One. 2023; 18(10):e0293598.

PMID: 37883518 PMC: 10602274. DOI: 10.1371/journal.pone.0293598.

Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group,....

Ravn E, Hasific S, Thomassen M, Hjortebjerg R, Bach Laursen K, Diederichsen A BMJ Open. 2023; 13(9):e074057.

PMID: 37699636 PMC: 10503331. DOI: 10.1136/bmjopen-2023-074057.

Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Ahmadimoghaddam D, Talebi S, Rahmani A, Zamanirafe M, Parvaneh E, Ranjbar A Eur J Clin Pharmacol. 2023; 79(10):1341-1356.

PMID: 37524929 DOI: 10.1007/s00228-023-03546-9.

NGAL as Biomarker of Clinical and Subclinical Damage of Kidney Function after Coronary Angiography.

Petrova I, Alexandrov A, Vladimirov G, Mateev H, Bogov I, Paskaleva I Diagnostics (Basel). 2023; 13(6).

PMID: 36980488 PMC: 10047760. DOI: 10.3390/diagnostics13061180.

Factors influencing the safety of outpatient coronary CT angiography: a clinical registry study.

Florian Andre , Fortner P, Emami M, Seitz S, Brado M, Guckel F BMJ Open. 2022; 12(8):e058304.

PMID: 35940836 PMC: 9364403. DOI: 10.1136/bmjopen-2021-058304.

References
1.
McCullough P, Wolyn R, Rocher L, Levin R, ONeill W . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103(5):368-75. DOI: 10.1016/s0002-9343(97)00150-2. View
2.
Thomsen H, Morcos S, Erley C, Grazioli L, Bonomo L, Ni Z . The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol. 2008; 43(3):170-8. DOI: 10.1097/RLI.0b013e31815f3172. View
3.
Sherwin P, Cambron R, Johnson J, Pierro J . Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol. Invest Radiol. 2005; 40(9):598-603. DOI: 10.1097/01.rli.0000174476.62724.82. View
4.
Katzberg R, Barrett B . Risk of iodinated contrast material--induced nephropathy with intravenous administration. Radiology. 2007; 243(3):622-8. DOI: 10.1148/radiol.2433061411. View
5.
Barrett B, Katzberg R, Thomsen H, Chen N, Sahani D, Soulez G . Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol. 2006; 41(11):815-21. DOI: 10.1097/01.rli.0000242807.01818.24. View